BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32557015)

  • 1. Quantitative evaluation of anti-resorptive agent-related osteonecrosis of the jaw using bone single photon emission computed tomography in clinical settings: relationship between clinical stage and imaging.
    Okui T; Kobayashi Y; Tsujimoto M; Satoh K; Toyama H; Matsuo K
    Ann Nucl Med; 2020 Sep; 34(9):620-628. PubMed ID: 32557015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of quantitative bone SPECT/CT for medication-related osteonecrosis of the jaw in clinical settings.
    Moridera K; Kitajima K; Yoshikawa K; Takaoka K; Tsuchitani T; Noguchi K; Kishimoto H; Yamakado K
    Jpn J Radiol; 2022 May; 40(5):492-499. PubMed ID: 34851501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone scan index of the jaw: a new approach for evaluating early-stage anti-resorptive agents-related osteonecrosis.
    Watanabe S; Nakajima K; Mizokami A; Yaegashi H; Noguchi N; Kawashiri S; Inokuchi M; Kinuya S
    Ann Nucl Med; 2017 Apr; 31(3):201-210. PubMed ID: 27995542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of quantitative bone SPECT/CT for evaluating medication-related osteonecrosis of the jaw treatment response.
    Moridera K; Kitajima K; Yoshikawa K; Takaoka K; Tsuchitani T; Noguchi K; Kishimoto H; Yamakado K
    Jpn J Radiol; 2023 Jul; 41(7):760-767. PubMed ID: 36656541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative SPECT/CT imaging for medication-related osteonecrosis of the jaw: a preliminary study using volume-based parameters, comparison with chronic osteomyelitis.
    Ogura I; Kobayashi E; Nakahara K; Igarashi K; Haga-Tsujimura M; Toshima H
    Ann Nucl Med; 2019 Oct; 33(10):776-782. PubMed ID: 31342316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathological findings affect quantitative values of single photon emission computed tomography in patients with antiresorptive agent-related osteonecrosis of the jaws.
    Okui T; Kobayashi Y; Isomura M; Tsujimoto M; Satoh K; Toyama H
    Fujita Med J; 2023 Aug; 9(3):186-193. PubMed ID: 37554942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring indices of bone inflammatory activity of the jaw using SPECT bone scintigraphy: a study of ARONJ patients.
    Hata H; Kitao T; Sato J; Asaka T; Ohga N; Imamachi K; Hirata K; Shiga T; Yamazaki Y; Kitagawa Y
    Sci Rep; 2020 Jul; 10(1):11385. PubMed ID: 32647190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of bone metastasis burden as an imaging biomarker by quantitative single-photon emission computed tomography/computed tomography for assessing prostate cancer with bone metastasis: a phantom and clinical study.
    Motegi K; Matsutomo N; Yamamoto T; Koizumi M
    Radiol Phys Technol; 2020 Sep; 13(3):219-229. PubMed ID: 32535819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of morphological findings in computed tomography on the quantitative values in single-photon emission computed tomography for patients with antiresorptive agent-related osteonecrosis of the jaw: a cross-sectional study.
    Kobayashi Y; Okui T; Tsujimoto M; Ikeda H; Satoh K; Kanamori D; Fujii N; Toyama H; Matsuo K
    Ann Nucl Med; 2021 Jul; 35(7):853-860. PubMed ID: 33997910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative bone scan imaging using BSI and BUV: an approach to evaluate ARONJ early.
    Yamamoto Y; Mitsunaga S; Horikawa A; Hino A; Kurihara H
    Ann Nucl Med; 2020 Jan; 34(1):74-79. PubMed ID: 31705367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maximum and mean standardized uptake values of medication-related osteonecrosis of the jaw with bone SPECT/CT: comparison of mandibular pathologies, control and temporomandibular joints.
    Tezuka Y; Ogura I
    Dentomaxillofac Radiol; 2023 Sep; 52(6):20230119. PubMed ID: 37395742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between Systemic Markers of Bone Turnover or Bone Mineral Density and Anti-Resorptive Agent-Related Osteonecrosis of the Jaw in Patients Treated with Anti-Resorptive Agents.
    Tohashi K; Nakabayashi M; Kodani I; Kidani K; Ryoke K
    Yonago Acta Med; 2016 Mar; 59(1):45-53. PubMed ID: 27046950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of maximum and mean standardized uptake values of jaw pathologies with bone SPECT/CT: an especial focus on medication-related osteonecrosis of the jaw.
    Minami Y; Ogura I
    Nucl Med Commun; 2022 Dec; 43(12):1188-1194. PubMed ID: 36345763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone single-photon emission computed tomography-CT peak standardized uptake value for chronic osteomyelitis, osteoradionecrosis and medication-related osteonecrosis of the jaw.
    Minami Y; Ogura I
    J Med Imaging Radiat Oncol; 2021 Apr; 65(2):160-165. PubMed ID: 33180378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of SPECT/CT and CBCT in patients with mandibular osteomyelitis and osteonecrosis.
    Malina-Altzinger J; Klaeser B; Suter VGA; Schriber M; Vollnberg B; Schaller B
    Clin Oral Investig; 2019 Dec; 23(12):4213-4222. PubMed ID: 30806799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorodeoxyglucose positron emission tomography with computed tomography detects greater metabolic changes that are not represented by plain radiography for patients with osteonecrosis of the jaw.
    Fleisher KE; Raad RA; Rakheja R; Gupta V; Chan KC; Friedman KP; Mourtzikos KA; Janal M; Glickman RS
    J Oral Maxillofac Surg; 2014 Oct; 72(10):1957-65. PubMed ID: 25053572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative bone SPECT/CT applications for cartilaginous bone neoplasms.
    Kitajima K; Futani H; Tsuchitani T; Takahashi Y; Tachibana T; Yamakado K
    Hell J Nucl Med; 2020; 23(2):133-137. PubMed ID: 32716404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Test-retest repeatability of quantitative bone SPECT/CT.
    Yamane T; Fukushima K; Shirotake S; Nishimoto K; Okabe T; Oyama M; Seto A; Kuji I
    Ann Nucl Med; 2021 Mar; 35(3):338-346. PubMed ID: 33400148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative [
    Tanaka K; Norikane T; Mitamura K; Yamamoto Y; Maeda Y; Fujimoto K; Takami Y; Ishimura M; Arai-Okuda H; Tohi Y; Kudomi N; Sugimoto M; Nishiyama Y
    EJNMMI Phys; 2022 Dec; 9(1):83. PubMed ID: 36469149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of bone scintigraphy in cancer patients with osteonecrosis of the jaw.
    Van den Wyngaert T; Huizing MT; Fossion E; Vermorken JB
    Clin Nucl Med; 2011 Jan; 36(1):17-20. PubMed ID: 21157201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.